Navigation Links
Study Analyzed SYMBICORT(R) in Children with Persistent Asthma
Date:5/20/2008

WILMINGTON, Del., May 20 /PRNewswire-FirstCall/ -- A new 12-week study(2) examined safety and efficacy measures of the maintenance combination asthma therapy, SYMBICORT(R) (budesonide/formoterol fumarate dehydrate) Inhalation Aerosol(2) in treating mild to moderate persistent asthma in children ages 6 to 15 years old(2) who were previously treated with an inhaled corticosteroid (ICS).(2) Of note, the study included efficacy assessments of nighttime symptoms, nighttime rescue medication use and rescue medication-free days in patients taking SYMBICORT compared to those taking formoterol dry powder inhaler (DPI) or budesonide pressurized metered-dose inhaler (pMDI). Results were presented today at the International Conference of the American Thoracic Society held in Toronto, Canada, May 16-21, 2008.

"Children with asthma, who are not adequately controlled by ICS therapy, may have their sleep affected by asthma symptoms,"(6) said Kathy Lampl, MD, Director, Clinical Research, AstraZeneca. "Combination therapy with inhaled ICS and LABA is one of the recommended regimens for children who have moderate to severe persistent asthma or are not controlled with ICS therapy alone, according to the NIH Guidelines."(7)

AstraZeneca (NYSE: AZN) anticipates filing a supplemental new drug application with the Food and Drug Administration for the pediatric indication of SYMBICORT in the first half of 2008.

About the Study (Abstracts #K66 and K67)

The safety profile and efficacy measures of SYMBICORT were assessed during a 12-week randomized, double-blind, active-controlled study that evaluated 411 children ages 6 to 15 years old with mild to moderate persistent asthma(1,2) previously treated with ICS therapy.(1,2) After a two-week p
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
3. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
4. Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
5. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
6. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
7. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
8. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
9. Amikacin Inhale Shows Promising Results in Phase II Study
10. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
11. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... A new survey of health care ... (CER) will yield improvements in health care decision-making, ... of CER in the current environment. The National ... shows that they view CER as important, expect ... and decision-making in the next three to five ...
(Date:3/26/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... to serve as a feature-rich resource for patients of its ... For those experiencing knee pain, the Gel-One Patient ... knee pain and helps them understand more about the potential ... non-surgical treatment option. For those who have had a ...
(Date:3/26/2015)... ROCKVILLE, Md. , March 26, 2015  RegeneRx ... that it has received a patent acceptance notice from ... beta 4 (TB4) to prevent or reduce tissue damage ... often the case when cardiac vessels are opened after ... circumstances when treating stroke victims. Damage can ...
Breaking Medicine Technology:NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4Zimmer Launches New Patient Education And Engagement Mobile App For Gel-One Hyaluronate 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3
... 16 BioVex Inc, a biotechnology,company developing clinical ... that the abstract describing the interim results,from its ... advanced metastatic,melanoma is now available at the American ... http://www.asco.org . A summary of the abstract,which describes ...
... Nektar,s Technology Enables First-Ever PEGylation of a Small Molecule with ... Demonstrated Therapeutic ... NKTR ) announced initial results today from a Phase ... activity in patients with refractory solid tumors. The study,also demonstrates ...
Cached Medicine Technology:BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... the Way, Brightening the Day, on Friday, May 1, ... Morristown, NJ. , Guests will enjoy an elegant ... delightful cuisine, an extensive silent auction and heart-warming testimony ... awards will be presented to this year’s honorees. ...
(Date:3/26/2015)... San Juan Capistrano, Calif. (PRWEB) March 26, 2015 ... monitoring equipment and repairs, is pleased to be featured ... the Discovery Channel on March 18, 2015. The ... status, and it is live on the Pacific Medical ... families that face life threatening emergencies, it is reassuring ...
(Date:3/26/2015)... Silver Spring, Md. (PRWEB) March 26, 2015 ... (PHA) fully supports the Patients’ Access to Treatments ... of Representatives this week by Reps. David B. ... bi-partisan legislation will limit cost-sharing requirements for medications ... medications more accessible by reducing patients’ out-of-pocket expenses. ...
(Date:3/26/2015)... FL (PRWEB) March 26, 2015 ... its brand-new, state-of-the-art company website: http://www.metabolicnutrition.com . ... the revamped website creates a user-friendly experience for ... company. , The new, enhanced Metabolic Nutrition ... information about the company’s diverse line of products, ...
(Date:3/26/2015)... Chicago, Ill. (PRWEB) March 26, 2015 ... celebrate the legacy of a man who revolutionized the ... (BCL) posthumously honored Leo Passage; founder of Pivot Point ... the award on behalf of Leo. Held at the ... by a “who’s who” of industry and media leaders ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... custom chopper!, PITTSBURGH, May 7 GNC ... Sonia Adcock at the Contra Costa Bodybuilding,Fitness and ... Performing,Arts Center in Hayward, Calif., Garcia and ... Federation,of Bodybuilding (IFBB) fitness and figure competitors. The ...
... DALLAS, May 7 The American Heart ... its second of the,planned six-publication extension to the ... Association. The journals will,be published by Lippincott Williams ... James E. Udelson, M.D., acting chief of the ...
... who speak a second or third language may have ... Aviv University study has found. Knowing and speaking many ... aging. , Dr. Gitit Kav, a clinical neuro-psychologist from ... together with her colleagues Nitza Eyal, Aviva Shorek, and ...
... Health, a global,provider of products and services that improve ... board of directors has approved a 17,percent increase in ... The regular quarterly dividend is payable on July 15 ... paid a 12-cents-per-share quarterly,dividend since July 15, 2007 and ...
... This release is available in Spanish ... Diabetes Federation (IDF) BRIDGES translational research grant program ... that will offer culturally appropriate and improved diabetes ... , The community-based study, Diabetes Self-Management Program (DSME), ...
... Patients, nurses,physicians and other hospital and healthcare advocates ... May 12 to protest the nearly $300,million in healthcare ... WHAT: "Care Today, Gone Tomorrow," a Rally to Preserve ... Street, Trenton, WHEN: 12 noon, May 12, ...
Cached Medicine News:Health News:Fitness and Figure Professionals Adela Garcia and Sonia Adcock to Represent GNC at Contra Costa Championship 2Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 2Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 3Health News:Tel Aviv University finds connection between mental fitness and multi-lingualism 2Health News:Cardinal Health Increases Quarterly Dividend by 17 Percent 2Health News:International Diabetes Federation gives grant to Philippine diabetes education program 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: